Xian-Bao Liu1, Yu-Xin He1, Chun-Hui Liu1, Li-Han Wang1, Feng Gao1, Lei Yu1, Ai-Qiang Dong2, Min-Jian Kong2, Ji-Fang Chen1, Yong Xu3, Qi-Jing Zhou4, Min Yan3, Jian-An Wang1. 1. Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 2. Department of Cardiovascular Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3. Department of Anesthesiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 4. Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract
BACKGROUND: No retrievable and repositionable second generation transcatheter aortic valve is available in China. Here, we report the first-in-man implantation of the retrievable and repositionable VenusA-Plus valve. METHODS: A 76-year-old patient with symptomatic severe aortic stenosis and high surgical risk (STS 13.8%) was recommended for transcatheter aortic valve replacement (TAVR) by heart valve team. Type 0 bicuspid aortic valve with asymmetric calcification was identified by dual source computed tomography, and the unfavorable anatomies increased the possibility of malposition and paravalvular leakage during TAVR. Therefore, we used the retrievable and repositionable VenusA-Plus valve for the patient. RESULTS: Transfemoral TAVR was performed under local anesthesia with sedation, and a 26mm VenusA-Plus valve was successfully implanted. No transvalvular pressure gradient and trace paravalvular leakage were found. CONCLUSION: The successful first-in-man implantation indicates the retrievable and repositionable VenusA-Plus valve is feasible in complicated TAVR cases such as bicuspid aortic valve.
BACKGROUND: No retrievable and repositionable second generation transcatheter aortic valve is available in China. Here, we report the first-in-man implantation of the retrievable and repositionable VenusA-Plus valve. METHODS: A 76-year-old patient with symptomatic severe aortic stenosis and high surgical risk (STS 13.8%) was recommended for transcatheter aortic valve replacement (TAVR) by heart valve team. Type 0 bicuspid aortic valve with asymmetric calcification was identified by dual source computed tomography, and the unfavorable anatomies increased the possibility of malposition and paravalvular leakage during TAVR. Therefore, we used the retrievable and repositionable VenusA-Plus valve for the patient. RESULTS: Transfemoral TAVR was performed under local anesthesia with sedation, and a 26mm VenusA-Plus valve was successfully implanted. No transvalvular pressure gradient and trace paravalvular leakage were found. CONCLUSION: The successful first-in-man implantation indicates the retrievable and repositionable VenusA-Plus valve is feasible in complicated TAVR cases such as bicuspid aortic valve.
Authors: Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano Journal: Eur Heart J Date: 2017-09-21 Impact factor: 29.983
Authors: Sung-Han Yoon; Sabine Bleiziffer; Ole De Backer; Victoria Delgado; Takahide Arai; Johannes Ziegelmueller; Marco Barbanti; Rahul Sharma; Gidon Y Perlman; Omar K Khalique; Erik W Holy; Smriti Saraf; Florian Deuschl; Buntaro Fujita; Philipp Ruile; Franz-Josef Neumann; Gregor Pache; Masao Takahashi; Hidehiro Kaneko; Tobias Schmidt; Yohei Ohno; Niklas Schofer; William K F Kong; Edgar Tay; Daisuke Sugiyama; Hiroyuki Kawamori; Yoshio Maeno; Yigal Abramowitz; Tarun Chakravarty; Mamoo Nakamura; Shingo Kuwata; Gerald Yong; Hsien-Li Kao; Michael Lee; Hyo-Soo Kim; Thomas Modine; S Chiu Wong; Francesco Bedgoni; Luca Testa; Emmanuel Teiger; Christian Butter; Stephan M Ensminger; Ulrich Schaefer; Danny Dvir; Philipp Blanke; Jonathon Leipsic; Fabian Nietlispach; Mohamed Abdel-Wahab; Bernard Chevalier; Corrado Tamburino; David Hildick-Smith; Brian K Whisenant; Seung-Jung Park; Antonio Colombo; Azeem Latib; Susheel K Kodali; Jeroen J Bax; Lars Søndergaard; John G Webb; Thierry Lefèvre; Martin B Leon; Raj Makkar Journal: J Am Coll Cardiol Date: 2017-03-18 Impact factor: 24.094
Authors: Jie Li; Yinghao Sun; Shengneng Zheng; Guang Li; Haojian Dong; Ming Fu; Yujing Mo; Yi Li; Huadong Liu; Zhaoyan Xu; Liting Zhang; Yong Cao; Ruixin Fan; D Scott Lim; Jianfang Luo Journal: Front Cardiovasc Med Date: 2021-07-12